Keating Investment Counselors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Keating Investment Counselors's LLY Position: Q1 2023 in Review
Keating Investment Counselors sold out of Eli Lilly (LLY) in Q1 2023, closing a stake of 635 shares — an estimated $232K sold.
Keating Investment Counselors first reported a position in LLY in Q4 2022 and held it in 1 quarter. The position peaked at $232K in Q4 2022. 2,615 funds tracked by Wall St. Rank hold LLY as of Q1 2023.
- Keating Investment Counselors reported no remaining Eli Lilly position as of Q1 2023 after selling out during the quarter.
- Keating Investment Counselors sold 635 Eli Lilly shares in Q1 2023, an estimated $232K.
- Keating Investment Counselors first reported a position in Eli Lilly in Q4 2022 and held it in 1 quarter.
- Keating Investment Counselors's Eli Lilly position peaked at $232K in Q4 2022.
- 2,615 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.
Based on Keating Investment Counselors's 13F filing for Q1 2023, filed 4 May 2023.